Cambridge Conversations: Early cancer detection and prevention: the Cambridge approach

Cambridge Conversations: Early cancer detection and prevention: the Cambridge approach

Cambridge Conversations: Early cancer detection and prevention: the Cambridge approach

event Thursday, July 18, 2024 schedule 7.00pm - 8.00pm BST
Past event
Past event
event Thursday, July 18, 2024 schedule 7.00pm - 8.00pm BST
  • Image of Professor Rebecca Fitzgerald
Open to: 
Alumni and guests

Join Professor Rebecca Fitzgerald and Professor Patrick Maxwell in conversation about how Cambridge is approaching early detection and prevention of cancer. They will discuss emerging opportunities for catching cancer earlier - even at pre-cancerous stages. Rebecca is pursuing this in her own work and as leader of the Li Ka Shing Early Cancer Institute.

In this thought-provoking discussion, they will consider questions such as:

  • Why has early detection become so important?
  • How early do we want to know about cancer?
  • What technologies have made this possible?
  • What else can we do to prevent cancer?
  • Why is a multidisciplinary approach key to research in early cancer detection and prevention?
  • What impact can universities have?


Cambridge Conversations

In April 2020, the university launched a series of webinars to give alumni digital access to the pre-eminent research at Cambridge. Covering a myriad of topics, our webinars give you the opportunity to watch our world-leading academics discuss key issues, and to take part in real-time Q&A sessions. Cambridge Conversations is now in its fifth year, allowing you to listen, connect and engage with current Cambridge thinking, wherever you are.

We will upload an edited recording of the webinar to YouTube after the event.


Professor Rebecca Fitzgerald OBE FRS FMedSci FRCP EMBO (Girton 1986, Clinical Medicine)

Photograph of Rebecca Fitzgerald

Rebecca Fitzgerald is a Professor of Cancer Prevention and Founding Director of the Li Ka Shing Early Cancer Institute at the University of Cambridge and practices medicine as Hon. Consultant in Gastroenterology and Cancer Medicine at Addenbrooke's Hospital. Rebecca is the Cambridge lead for the CRUK International Alliance in Early Detection (ACED). Her research aims to understand how tissues become cancerous and whether identifying pre-cancer at scale can reduce cancer morbidity and mortality, focussing on the oesophagus and stomach. Her work to develop and implement a non-endoscopic capsule sponge and related biomarker assays for detection of Barrett's oesophagus and associated dysplasia has been awarded several prizes including the Westminster Medal, an NHS Innovation prize and the Don Listwin Early Detection Prize. In 2022 Rebecca was awarded an OBE for services to cancer research. Rebecca has contributed to evidence reviews and policy work around screening including for the Department of Health in the UK and recently led a review of cancer screening for the European Commission that led to new screening policy for EU member states.

Professor Patrick Maxwell FMedSci

Photograph of Patrick Maxwell

Patrick Maxwell is Regius Professor of Physic and Head of the School of Clinical Medicine at the University of Cambridge.

As a clinician scientist, he has been centrally involved in a series of discoveries that have revealed how changes in oxygenation are sensed, and how genetic alterations cause kidney disease.

Patrick is a Fellow of the Royal College of Physicians and the Academy of Medical Sciences, Director of Cambridge University Health Partners and a Non-Executive Director of Cambridge University Hospitals, Cambridge Enterprise, Scottish Mortgage Investment Trust and the International Biotechnology Turst.

Booking information


Booking for this event is now closed.